B Group, Inc.

13D and 13G Filings

Issuer % of Class Filed
Schedule 13G · 2 securities · passive
Retension Pharmaceuticals, Inc. 13G
RTSN · 76135H100
10.0% 10/16/2026
Event 10/13/2026
NRx Pharmaceuticals, Inc. 13G
NRXP · 629444209
12.6% 8/21/2025
Event 8/18/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.